WO2008156883A2 - Tear film measurement - Google Patents

Tear film measurement Download PDF

Info

Publication number
WO2008156883A2
WO2008156883A2 PCT/US2008/057578 US2008057578W WO2008156883A2 WO 2008156883 A2 WO2008156883 A2 WO 2008156883A2 US 2008057578 W US2008057578 W US 2008057578W WO 2008156883 A2 WO2008156883 A2 WO 2008156883A2
Authority
WO
WIPO (PCT)
Prior art keywords
eye
lipid layer
specularly reflected
light
interference
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2008/057578
Other languages
English (en)
French (fr)
Other versions
WO2008156883A3 (en
Inventor
Donald R. Korb
Benjamin T. Gravely
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TearScience Inc
Original Assignee
TearScience Inc
Kolis Scientific Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TearScience Inc, Kolis Scientific Inc filed Critical TearScience Inc
Priority to JP2010513285A priority Critical patent/JP5665181B2/ja
Priority to EP08732520A priority patent/EP2166922A4/en
Publication of WO2008156883A2 publication Critical patent/WO2008156883A2/en
Anticipated expiration legal-status Critical
Publication of WO2008156883A3 publication Critical patent/WO2008156883A3/en
Ceased legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01BMEASURING LENGTH, THICKNESS OR SIMILAR LINEAR DIMENSIONS; MEASURING ANGLES; MEASURING AREAS; MEASURING IRREGULARITIES OF SURFACES OR CONTOURS
    • G01B11/00Measuring arrangements characterised by the use of optical techniques
    • G01B11/02Measuring arrangements characterised by the use of optical techniques for measuring length, width or thickness
    • G01B11/06Measuring arrangements characterised by the use of optical techniques for measuring length, width or thickness for measuring thickness ; e.g. of sheet material
    • G01B11/0616Measuring arrangements characterised by the use of optical techniques for measuring length, width or thickness for measuring thickness ; e.g. of sheet material of coating
    • G01B11/0675Measuring arrangements characterised by the use of optical techniques for measuring length, width or thickness for measuring thickness ; e.g. of sheet material of coating using interferometry
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B3/00Apparatus for testing the eyes; Instruments for examining the eyes
    • A61B3/10Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
    • A61B3/101Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for examining the tear film

Definitions

  • This invention relates generally to the field of measurement of the tear film thickness on the precorneal surface of the eye and more particularly, to the measurement of the thickness of the outermost layer of the tear film, i.e., the lipid layer.
  • the human precorneal tear film is comprised of three primary layers, each of which serves a specific function.
  • the innermost layer of the precorneal tear film provides a protective environment for the superficial epithelial cells of the cornea and helps protect against microbes and foreign bodies.
  • the outer surface of the precorneal tear film is the primary refracting surface of the eye. Its surface tension helps to smooth this surface, thus improving the optical quality of the image ultimately impacting the retina. Additionally, the precorneal tear film provides a lubricating function during blinking. These structures are often disrupted in dry eye conditions, which are some of the most common ophthalmic disorders seen by eye-care practitioners.
  • Dry eye disorders and/or disease can lead to premature breakup of the tear film after a blink, leading to damage of the superficial epithelium which may result in discomfort and be manifested as optical blur.
  • the ability of a patient to wear contact lenses is a direct function of the quality and quantity of the tear film, and dry eye disorders and/or disease therefore has a significant impact on contact lens wear parameters.
  • the precorneal tear film is comprised of an inner mucin layer, a middle aqueous layer, and an outermost thin lipid layer.
  • Various treatments are used in an attempt to alleviate dry eye symptoms. For example, it has been proposed to treat certain dry eye conditions by the application of heat and pressure to unclog meibomian glands, or with pharmaceutical methods to unclog meibomian gland and to stimulate tear production.
  • lipid layer thickness values Following calibration with Eastman Kodak color reference standards (Wratten filters), the static and dynamic appearance of the lipid layer was observed before and after blinking. During the observation period, the subject was instructed to blink naturally while gazing at a fixation target. For purposes of quantization and standardization, a specific region of the tear film was designated for analysis. This area encompassed a zone approximately one mm above the lower meniscus to slightly below the inferior pupillary margin, averaging 7-8 mm wide and 2.5 mm in height. The dominant color of the specularly reflected light within this designated area was used as the basis for assigning lipid layer thickness values.
  • Thickness values were assigned to specific colors on the basis of prior work on tear film lipid layer interference colors (McDonald, 1969; Norn.; 1979; Guilon, 1982; Hamano et al., 1982) and are summarized in Table 1. To confirm the lipid layer thickness values assigned to each subject's tear film lipid layer, recordings were independently graded by two observers masked as to subject identity. (Korb, DR, Baron DF, Herman JP, et al., Tear Film Lipid Layer Thickness as a Function of Blinking, Cornea
  • Doane discloses a Method and Device for in Vivo Wetting Determinations wherein a contact lens is illuminated with coherent light and the pre-lens tear film is imaged in such a way as to form an interference pattern. The image formed thereby is recorded and the tear film thickness is determined by correlating the interference bands of the recorded image.
  • a coherent light source and a camera are focused at the pre-lens film to image specularly reflected light from the front and rear surfaces of the tear film.
  • a film motion analyzer provides numerical coordinates of interference bands, and a microprocessor analyses the coordinates to provide a quantitative measure of lens position or wetting characteristics. Again, while knowledge of the tear film thickness covering the contact lens surface may be useful in the context of contact lens fitting, the Doane apparatus does not specifically measure lipid layer thickness on the natural eye.
  • Tearscope Plus manufactured by Keeler Instruments Inc., of Broomall, PA and Berkshire, UK. More specifically, the Tearscope is a hand-held or slit lamp mounted device that comprises a tubular housing which contains a coaxially mounted cylindrical light source. The interior bore of the housing is covered with a cylindrical diffuser plate that diffuses the light.
  • the eye- care practitioner places one end of the tube proximate the patient's eye thus illuminating the whole eye, including the pupil, and observes the interference patterns on the pupil surface through the opposite end of the tube, The color of the interference pattern generated by blinking is then correlated to tear film thickness.
  • the Tearscope is not without its inherent drawbacks and deficiencies as the process by which the eye is illuminated and the measurement is made introduces error which is diagnostically unacceptable.
  • the proximity of the illuminator to the eye surface when combined with the light intensity required to obtain a viewable interference pattern can cause reflex tearing.
  • the illumination system employed illuminates the entire eye, including the pupil.
  • light from the Tearscope is directed on to the retinal surface which, in turn causes a proprioceptive response which also skews measurement accuracy.
  • Another object of the present invention is to provide a method and apparatus that allows the accurate measurement of the thickness of the lipid layer component of the precorneal tear film.
  • a further object of the present invention is to provide a method and apparatus wherein the lipid layer thickness of the precorneal tear film may be measured without the introduction of reflex tearing.
  • a still further object of the present invention is to provide a method and apparatus that enhances contract and thereby the observability and measurablity of the lipid layer thickness of the precorneal tear film.
  • Yet another object of the present invention is to provide a method and apparatus for measuring the lipid layer thickness of the precorneal tear film using a low level of light in order to minimize tear film evaporation that can alter the measurement.
  • the invention comprises an apparatus for measuring the thickness of the lipid layer component of the precorneal tear film on the surface of an eye after distribution of the lipid layer subsequent to blinking.
  • An illuminator directs light to the lipid layer of a patient's eye.
  • a means for observing the specularly reflected light rays is provided.
  • the illuminator is a broad spectrum, large area lambertian light source covering the visible region, the rays of which are specularly reflected from the lipid layer and undergo constructive and destructive interference in the lipid layer.
  • a collector such as a camera or slit lamp may be provided to collect and focus the specularly reflected light such that the interference patterns on the tear film lipid layer are observable.
  • the collector also produces an output signal representative of the specularly reflected light which is suitable for further analysis, such as projection on to a high resolution video monitor or analysis by or storage in a computer.
  • the interference patterns of the specularly reflected light may be directly observed by the clinician and recorded.
  • the patient's head may be positioned on an observation platform, for example, a slit lamp stand, when the illuminator directs light to the lipid layer of the patient's eye.
  • the illuminator is sized to show the interference pattern of the lipid layer over the whole eye, (termed herein the "whole eye illuminator"), with the provision that the intensity of the light entering the pupil and striking the retina are below the threshold at which appreciable measurement error is introduced, i.e., the reflex tear and proprioceptive responses are not activated.
  • Observation of the interference pattern in the preferred embodiment is through an opening in the illuminator.
  • the illuminator is sized to show the interference pattern of the lipid layer below the pupil, (termed herein the "half eye illuminator"), such that the intensity of the light entering the pupil is extremely low, thus avoiding the introduction of virtually all system-induced inaccuracy. Observation of the interference pattern in this second embodiment is from above the illuminator.
  • Figure 1 is a side view of the tear film analyzer according to the present invention mounted to a stand with a patient positioned for viewing of interference fringes on the lipid layer of the eye.
  • the illuminator portion is shown as a vertical cross section through the center.
  • Figure 2 is a plan view of the tear film analyzer according to the present invention mounted to a stand with a patient positioned for viewing of interference fringes on the lipid layer of the eye.
  • Figure 3a is a side view of a second embodiment of the tear film analyzer according to the present invention mounted to a stand with a patient positioned for viewing of interference fringes on the lipid layer of the eye.
  • the illuminator portion is shown as a vertical cross section through the center.
  • Figure 3b is a side view of the second embodiment of the tear film analyzer according to the present invention mounted to a stand and tilted with a patient positioned for viewing of interference fringes on the lipid layer of the eye.
  • the illuminator portion is shown as a vertical cross section through the center.
  • Figure 4a is a plan view of the second embodiment of the tear film analyzer according to the present invention mounted to a stand with a patient positioned for viewing of interference fringes on the lipid layer of the eye.
  • Figure 4b is a plan view of the second embodiment of the tear film analyzer according to the present invention mounted to a stand and tilted with a patient positioned for view of interference fringes on the lipid layer of the eye.
  • Figure 5a is a plan view of the second embodiment of the tear film analyzer according to the present invention illustrating the illuminator surface that produces the outer edges of the viewable area of interference fringes.
  • Figure 5b is a side view of the second embodiment of the tear film analyzer according to the present invention illustrating the illuminator surface positioned below the plane of the pupil and tilted at an angle and showing the outer edges of the viewable area of interference fringes.
  • Figure 5c is a side view of the second embodiment of the tear film analyzer according to the present invention illustrating the illuminator surface vertically positioned below the plane of the pupil and showing the outer edges of the viewable area of interference fringes.
  • Figure 6 is a perspective view, partially exploded, of the full eye illuminator according to the present invention.
  • Figure 7 is a plan view, sectioned horizontally through the center of the viewing hole of the full eye illuminator according to the present invention.
  • Figure 8 is an end view, sectioned vertically through the center of the full eye illuminator according to the present invention.
  • Figure 9 is a perspective view, partially exploded of the half eye illuminator according to the present invention.
  • Figure 10 is a plan view with the top removed of the half eye illuminator according to the present invention.
  • Figure 1 1 is an end view, sectioned vertically through the center of the half eye illuminator according to the present invention.
  • Figure 12 is a front view of the surface of an eye and illustrating schematically the area defined by the extreme lambertion rays wherein interference patterns are viewable.
  • the apparatus broadly comprises an illumination means 100 and a means for observing the specularly reflected light 200.
  • a second embodiment best shown in figures 3a, 3b, 5a-5c and 9-1 1 , referred to herein as the "half eye” illuminator is shown.
  • the mode of operation of the two embodiments is substantially identical and they will therefore be described together using the same reference numerals and where differences between the embodiments occur, they will be discussed.
  • the illumination means 100 for directing light to the lipid layer of the patient's eye comprises a large area broad spectrum light source covering the visible region and being a lambertian emitter adapted to be positioned in front of the eye on a stand 300.
  • the terms "lambertion surface” and “lambertian emitter” are defined to be a light emitter having equal intensity in all directions.
  • the light source comprises a large surface area emitter, arranged such that rays emitted from the emitter are specularly reflected from the lipid layer and undergo constructive and destructive interference in the lipid layer. An image of this surface is the backdrop over which the interference image is seen and it should be as spatially uniform as possible.
  • the illumination means 100 illuminates a large area of the face which creates a 2.5mm high by 5mm long viewable area centered beneath the pupil 310 (see figure 12) which is adequate for lipid layer thickness determination and correlation to dry eye.
  • viewable area it is meant the active area that satisfies the criteria for viewing interferences fringes; i.e., approximately 2.5 mm x 7 mm for the half eye illuminator.
  • Full-eye illumination, excluding the pupil area, reveals additional information about the whole eye pattern of lipid distribution.
  • the geometry of the illuminator 100 can be most easily understood by starting from the camera lens and proceeding forward to the eye and then to the illuminator.
  • 0 2 .
  • the present invention it is necessary to determine only the extreme rays (the ones at the outermost boundary of the desired viewing area) to define the area of the illuminator. Since the surface of that portion of the eye to be examined is approximately spherical, a line drawn from the camera lens (or the observer's eye) to the edge of the viewing area on the observed eye will reflect at the same angle on the other side of the line normal to the eye surface at the point of intersection of the line with the eye. When the half eye illuminator used, it may be tilted to better accommodate the nose and illuminate a larger area of the inferior lipid layer.
  • the illumination means 100 is a broad spectrum light source covering the visible region between about 400 nm to about 700 nm.
  • white Light Emitting Diodes (“LEDs”) 120 were used that have a 50° forward projection angle, 25OOmcd typical intensity, and 5mm diameter (part number NSPW51 OCS, available from Nichia Corporation, Wixom, MI).
  • LEDs white Light Emitting Diodes
  • the light emitting array platform 130 (Figs. 6, 7) into which the LEDs are mounted had a curved surface, subtending an arc of approximately 130° from the optical axis of the eye (see Fig 5a).
  • a housing is formed around the LED array platform 130 by a pair of side panels 135, bottom and top panels 140, rear panel 145 and the diffuser means or diffuser 150.
  • the respective diffuser 150, LED platform 130, and rear panel 145 are flexible and fit within grooves 147 located in the top and bottom panels 140 and the end pieces 135. The entire assembly is snapped together and the side panels 135 are then screwed to top and bottom panels 140.
  • illumination means 100 illustrated in the figures is curved or arcuate and has a radius of 7.620 inches from the center of the eye under examination, it could be flat as long as it subtends 130° around the eye.
  • a curved surface is more efficient in doing this, as the geometry yields a smaller device which is easier for the practitioner to use in a clinical setting.
  • the total power radiated from the illuminator 100 must be kept to a minimum to prevent accelerated tear evaporation.
  • air currents generated by heating or cooling systems can also cause excess evaporation and must be minimized (preferably eliminated) to maintain measurement accuracy.
  • the brightness, or intensity, measured in ⁇ W/mm 2 entering the pupil can cause reflex tearing, squinting, and other visual discomforts, all of which affect measurement accuracy.
  • the curved lambertian emitter includes a centrally positioned hole defining an opening 160 through which the means for collecting and focusing the specularly reflected light, i.e., a camera, eye, or other lens 200, is positioned.
  • the opening 160 in the center substantially prevents direct illumination from entering the pupil of the test eye. While less than optimal, the opening 160 could be located in other parts of the illuminator.
  • the other eye has the full light intensity entering the pupil. If the illumination intensity is low enough, the exposed eye does not react.
  • the exposed eye may also be occluded with a mask, or the illuminator may be segmented so that parts of the surface are not illuminated.
  • the half-eye illuminator stops below the centerline of the eye and does not directly illuminate either pupil or stated otherwise, light rays can only enter the pupil obliquely and do not impinge on the retina.
  • the current full-eye illuminator has a brightness or illumination intensity of between about 3 ⁇ W/mm 2 and 15 ⁇ W/mm 2 with about 4.5 ⁇ W/mm 2 at the surface of the illuminator being preferred, which is held 1-2 inches from the eye.
  • the total radiated power is less than I W and preferably no more than 40OmW. Brightness above about 6 ⁇ W/mm 2 becomes uncomfortable to the second eye if it enters the pupil so as to impinge directly on the retina.
  • the front surface of the illuminator is the lambertian emitter, i.e., all points on the extended illuminator surface are lambertian emitters, and comprises a flexible white translucent acrylic plastic sheet 150 approximately 1/16 inch thick that serves the function of diffusing the light emitted from a plurality of LED point sources and transforming them into the uniform Lambertian emitter.
  • the means for collecting and for focusing the specularly reflected light such as a high sensitivity color camera 200 should be employed.
  • the video camera, slit lamp or other observation apparatus 200 is positioned in opening 160 and is also mounted on stand 300 as shown in figure 2 or in the case of the half eye illuminator positioned above the emitter as per figures 3a and 3b.
  • Detailed visualization of the image patterns requires a means for collecting the specularly reflected light and for focusing the specularly reflected light such that the interference patterns from the lipid layer are observable.
  • Good digital imaging requires a CCD video camera having a resolution of up to 1280 x 1024 pixels and at least 15 Hz frame rate to show the progression of lipid interference patterns as they spread across the eye.
  • the AVT Dolphin 145C, 2/3 inch, CCD camera with 6.45 ⁇ m 2 pixels meets the requirements and outputs a signal representative thereof which may serve as the input signal to any one of a number of devices such as a video monitor (preferably high resolution) or a computer for analysis and/or archiving purposes.
  • the lens system employed in the instant tear film analyzer images a 15 - 40mm dimension in the sample plane (the eye) onto the active area of the CCD detector (e.g. ⁇ 10mm horizontal dimension for a 2/3 in. CCD).
  • the lens f-number should be as low as practical to capture maximum light and minimize the illumination power needed for a good image.
  • the lens chosen for the half-eye and full-eye systems is the Navitar Zoom 7000 close focus zoom lens for 2/3in. format CCDs. At lower magnification (25-40mm field of view), the eye and lids can be examined to observe the relationship of the blink to the lipid layer thickness. A more detailed analysis of the lipid layer can be obtained with a slightly higher magnification showing a 15- 25mm field of view.
  • the lipid layer thickness is not uniform and is classified on the basis of the most dominant color present in the interference pattern. It is believed that the lipid layer for most individuals cannot exceed 180 nm, and since thicker lipid layers provide better protection from evaporation than thinner lipid layers, thicker lipid layers provide greater protection against the development of dry eye states. Thinner lipid layers are associated with dry eye states and dry eye symptoms, particularly if the lipid layer thickness is less than 75nm.
  • the present system displays the interference patterns from white light incident on the lipid layer film.
  • the relation between the colors of the interference pattern and the lipid layer thickness (LLT) are shown in Table 1.
  • brown can be obtained in an additive process by mixing small intensities of red and green, or orange and blue, basically the opposite ends of the visible light spectrum. Alternatively, brown can be obtained in a subtractive process by filtering out the central yellow-green colors from the white spectrum, leaving a blue- orange mix.
  • the thickness of the lipid layer on the eye is much smaller than all the wavelengths of visible light. Therefore, full wavelength interference patterns are believed not to be possible.
  • the intensity in the interference pattern decreases rapidly as n increases and the ability to differentiate weak interference patterns from the background decreases accordingly.
  • the present invention demonstrates the results of subtractive colors, where subtracting the blue end from white light leaves a reddish tint, subtracting the center (yellow-green) from the spectrum leaves a brownish tint, and subtracting orange-red leaves a blue tint. Because all the interference patterns are fractional wavelengths, and therefore relatively weak in intensity, the images are not strongly saturated. Image enhancement techniques therefore assume a higher importance for good visibility. Film thickness below about 90nm can be determined by gray scale analysis.
  • the term "real time" is defined as data transfer, storage and retrieval at a rate required for image generation that the observer requires for a subjectively satisfactory viewing experience.
  • a minimum of about 15 frames per second is satisfactory for seamless motion perception.
  • the camera can create 1.4-3.9MB images at 15 per second, or 21-57MB/sec which must be processed by the computer for storage, display, or computation.
  • one minute of recording requires 1.26-3.42GB of storage.
  • the data from the camera must be streamed directly to a storage system sized to meet the anticipated volume of data. For example, 500 GB of storage could record 147-397 tests of one minute duration.
  • Various forms of data management could be applied to reduce the storage requirements, including image size, compression, and minimizing recording time adequate to good diagnostics.
  • the software to operate the camera, capture the images, store and retrieve image files, and execute chosen calculations on the data is critical to the success of the system.
  • Relevant specifications are:
  • the mechanical system consists of components to position the patient's head, position the illuminator and camera, focus the camera, and switch position between eyes.
  • a movable frame positions the camera and illuminator opposite the patient's face.
  • the illuminator and camera move together in a gross manner, but the illuminator has an independent X and rotational motions for accommodating different facial geometries.
  • Switching from eye to eye requires moving the whole camera/illuminator frame away from the patients face (X motion) and horizontally to line up with the second eye (Y motion).
  • Focusing the camera requires fine control of X motion, and vertical Z motion is required to accommodate differences in patient eye positions.
  • a classical slit lamp biomicroscope stand incorporates most of these motions, and have added angular motions not needed in the present system.
  • Figuresl, 2, 3a-3c illustrate the full-eye system.
  • a typical examination session proceeds as follows: Presets: The vertical relationship between the camera and the illuminator is set. For a half- eye illuminator, the camera position is just enough higher than the illuminator top edge that the image contains no edge effects. When using the full-eye illuminator, the camera is positioned coaxially with the hole through the illuminator. The camera/illuminator position should not need adjusting thereafter.
  • the patient is seated and asked to place their chin on the chin rest.
  • the chin rest is adjusted (Z axis) for the comfort of the patient.
  • the patient is asked to hold their forehead against the forehead rest.
  • the frame holding the camera & illumination is positioned on the axis of the first eye and brought close enough for rough focus on the skin.
  • the frame is adjusted for vertical and horizontal centering, and then moved forward for fine focusing.
  • the illuminator is adjusted forward and back, and rotated for best illumination of the eye. Repeat fine focus as necessary. The patient is asked to look directly at the center or top center of the camera lens. Instructions are given to the patient for blinking regimens by the diagnostician.
  • the images are viewed and recorded as desired.
  • the frame may be pulled away from the patient (to clear the nose) and moved horizontally to the next eye. Steps 2.-5 are repeated.
  • the system could be fully motorized and operated in manual, semi-autonomous, or autonomous modes, depending upon the sophistication of the control software.
  • a fully automatic system would adjust the mechanical stand, focus the camera, record the motion of the lipid film, calculate various measurements of the film structure, report an assessment of the quality of the lipid film, and record the data in the patient's record file.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Physics & Mathematics (AREA)
  • Eye Examination Apparatus (AREA)
  • Length Measuring Devices By Optical Means (AREA)
PCT/US2008/057578 2007-06-20 2008-03-20 Tear film measurement Ceased WO2008156883A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2010513285A JP5665181B2 (ja) 2007-06-20 2008-03-20 涙液層測定
EP08732520A EP2166922A4 (en) 2007-06-20 2008-03-20 TEAR FILM MEASUREMENT

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/820,664 US7758190B2 (en) 2007-06-20 2007-06-20 Tear film measurement
US11/820,664 2007-06-20

Publications (2)

Publication Number Publication Date
WO2008156883A2 true WO2008156883A2 (en) 2008-12-24
WO2008156883A3 WO2008156883A3 (en) 2009-12-30

Family

ID=40136138

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/057578 Ceased WO2008156883A2 (en) 2007-06-20 2008-03-20 Tear film measurement

Country Status (4)

Country Link
US (3) US7758190B2 (enExample)
EP (1) EP2166922A4 (enExample)
JP (1) JP5665181B2 (enExample)
WO (1) WO2008156883A2 (enExample)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012522594A (ja) * 2009-04-01 2012-09-27 テイアサイエンス・インコーポレーテツド 眼球涙液膜の画像形成、処理および/または表示を行いおよび/または眼球涙液膜層の厚さを測定する、眼球表面の干渉分光(osi)装置、システムおよび方法
US8915592B2 (en) 2009-04-01 2014-12-23 Tearscience, Inc. Apparatuses and methods of ocular surface interferometry (OSI) employing polarization and subtraction for imaging, processing, and/or displaying an ocular tear film
US9642520B2 (en) 2009-04-01 2017-05-09 Tearscience, Inc. Background reduction apparatuses and methods of ocular surface interferometry (OSI) employing polarization for imaging, processing, and/or displaying an ocular tear film
US9668647B2 (en) 2012-12-21 2017-06-06 Tearscience Inc. Full-eye illumination ocular surface imaging of an ocular tear film for determining tear film thickness and/or providing ocular topography
US9795290B2 (en) 2013-11-15 2017-10-24 Tearscience, Inc. Ocular tear film peak detection and stabilization detection systems and methods for determining tear film layer characteristics
US9888839B2 (en) 2009-04-01 2018-02-13 Tearscience, Inc. Methods and apparatuses for determining contact lens intolerance in contact lens wearer patients based on dry eye tear film characteristic analysis and dry eye symptoms
US10278587B2 (en) 2013-05-03 2019-05-07 Tearscience, Inc. Eyelid illumination systems and method for imaging meibomian glands for meibomian gland analysis

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060210616A1 (en) * 2005-03-17 2006-09-21 Linder Barry J Therapeutic patch for ophthalmologic and cosmetic use
AU2008247423B2 (en) 2007-05-04 2013-10-31 Abbott Medical Optics Inc. Methods and devices for measuring tear film and diagnosing tear disorders
US7959293B2 (en) * 2007-05-04 2011-06-14 Abbott Medical Optics Inc. Methods and devices for measuring tear film and diagnosing tear disorders
US7758190B2 (en) 2007-06-20 2010-07-20 Tearscience, Inc. Tear film measurement
US8192026B2 (en) * 2007-06-20 2012-06-05 Tearscience, Inc. Tear film measurement
JP5894364B2 (ja) * 2007-08-16 2016-03-30 ザ スキーペンズ アイ リサーチ インスティチュート インコーポレイテッド 眼および付属器組織の炎症を処置するための治療組成物
USD614774S1 (en) 2008-12-18 2010-04-27 Tearscience, Inc. Ocular imaging apparatus
US8888286B2 (en) 2009-04-01 2014-11-18 Tearscience, Inc. Full-eye illumination ocular surface imaging of an ocular tear film for determining tear film thickness and/or providing ocular topography
US8215775B2 (en) * 2010-09-07 2012-07-10 United Integrated Services Co., Ltd. Method for analyzing tear film thermograph of contactless tear film thermal imager
US8696117B2 (en) 2010-09-14 2014-04-15 Truform Optics Fitting a contact lens
AU2011328900B2 (en) 2010-11-16 2015-03-19 The Board Of Trustees Of The Leland Stanford Junior University Systems and methods for treatment of dry eye
US9821159B2 (en) 2010-11-16 2017-11-21 The Board Of Trustees Of The Leland Stanford Junior University Stimulation devices and methods
DE102011081827A1 (de) * 2011-08-30 2013-02-28 Oculus Optikgeräte GmbH Ophthalmologisches Analysegerät und Verfahren
DE102011081825B4 (de) * 2011-08-30 2013-10-10 Oculus Optikgeräte GmbH Ophthalmologisches Analysegerät und Verfahren
US8602557B2 (en) 2011-12-02 2013-12-10 Abbott Medical Optics Inc. Method for calculating tear film lipid and aqueous layer thickness and corneal surface refractive index from interferometry data
US9724230B2 (en) 2012-01-04 2017-08-08 Sight Sciences, Inc. Dry eye treatment apparatus and methods
US10973680B2 (en) 2012-01-04 2021-04-13 Sight Sciences, Inc. Controller for dry eye treatment systems
US11285040B2 (en) 2012-01-04 2022-03-29 Sight Sciences, Inc. Combination treatment systems
US9510972B2 (en) 2012-01-04 2016-12-06 Sight Sciences, Inc. Dry eye treatment systems
WO2013166477A2 (en) 2012-05-04 2013-11-07 Tearscience, Inc. Apparatuses and methods for determining tear film break-up time and/or for detecting lid margin contact and blink rates, particularly for diagnosing, measuring, and/or analyzing dry eye conditions and symptoms
US9400330B2 (en) * 2012-10-19 2016-07-26 Schweitzer Engineering Laboratories, Inc. Manipulation resilient time distribution network
US20140132949A1 (en) * 2012-11-14 2014-05-15 Colton Beavers Sunglass Testing Station
WO2014138709A1 (en) 2013-03-08 2014-09-12 Oculeve, Inc. Devices and methods for treating dry eye in animals
EP2967817B1 (en) 2013-03-12 2021-03-10 Oculeve, Inc. Implant delivery devices and systems
JP6795975B2 (ja) 2013-04-19 2020-12-02 オキュリーブ, インコーポレイテッド 鼻刺激デバイス及び方法
MX2016011118A (es) 2014-02-25 2016-12-05 Oculeve Inc Formulaciones de polimeros para estimulacion nasolagrimal.
US10368738B2 (en) 2014-06-06 2019-08-06 Johnson & Johnson Surgical Vision, Inc. Fast absolute-reflectance method for the determination of tear film lipid layer thickness
US9456741B2 (en) 2014-06-06 2016-10-04 Abbott Medical Optics Inc. Method for rapid calculation of tear film lipid and aqueous layer thickness and ocular surface refractive index from interferometry spectra
US9681802B2 (en) 2014-06-06 2017-06-20 Abbott Medical Optics Inc. Fast absolute-reflectance method for the determination of tear film lipid layer thickness
EP3171928B1 (en) 2014-07-25 2020-02-26 Oculeve, Inc. Stimulation patterns for treating dry eye
EP3209370A4 (en) 2014-10-22 2018-05-30 Oculeve, Inc. Contact lens for increasing tear production
US9737712B2 (en) 2014-10-22 2017-08-22 Oculeve, Inc. Stimulation devices and methods for treating dry eye
CA2965363A1 (en) 2014-10-22 2016-04-28 Oculeve, Inc. Implantable nasal stimulator systems and methods
CA2980289C (en) 2015-03-20 2024-05-14 Glaukos Corporation Gonioscopic devices
USD775356S1 (en) * 2015-09-24 2016-12-27 Clarity Medical Systems, Inc. Instrument for measuring optical wave front
US10426958B2 (en) 2015-12-04 2019-10-01 Oculeve, Inc. Intranasal stimulation for enhanced release of ocular mucins and other tear proteins
US10252048B2 (en) 2016-02-19 2019-04-09 Oculeve, Inc. Nasal stimulation for rhinitis, nasal congestion, and ocular allergies
US10918864B2 (en) 2016-05-02 2021-02-16 Oculeve, Inc. Intranasal stimulation for treatment of meibomian gland disease and blepharitis
WO2018102535A1 (en) 2016-12-02 2018-06-07 Oculeve, Inc. Apparatus and method for dry eye forecast and treatment recommendation
US10674906B2 (en) 2017-02-24 2020-06-09 Glaukos Corporation Gonioscopes
USD833008S1 (en) 2017-02-27 2018-11-06 Glaukos Corporation Gonioscope
USD935619S1 (en) * 2017-09-29 2021-11-09 Haag-Streit Ag Optical device
US11564563B2 (en) 2018-02-17 2023-01-31 Aizhong Zhang Apparatus and method of a multifunctional ophthalmic instrument
EP3801195B1 (en) 2018-06-05 2025-09-17 Alcon Inc. Apparatus and method for in-vivo measurement of corneal biomechanical response
US12263115B2 (en) 2018-09-11 2025-04-01 Sight Sciences, Inc. Forceps treatment systems
WO2020071140A1 (en) * 2018-10-04 2020-04-09 Topcon Corporation Ophthalmologic device and method of operating ophthalmologic device
EP3893842A1 (en) 2018-12-10 2021-10-20 Eternatear, Inc. Ophthalmic formulations providing durable ocular lubrication
US11503995B2 (en) 2019-04-24 2022-11-22 Topcon Corporation Ophthalmologic apparatus
JP7658051B2 (ja) 2019-04-24 2025-04-08 株式会社トプコン 眼科装置
US11185220B2 (en) * 2019-04-24 2021-11-30 Topcon Corporation Ophthalmologic apparatus
US12446771B2 (en) 2019-06-28 2025-10-21 Topcon Corporation 2D multi-layer thickness measurement
US11253151B2 (en) 2019-09-08 2022-02-22 Aizhong Zhang Multispectral and hyperspectral ocular surface evaluator
KR102418347B1 (ko) * 2020-10-20 2022-07-07 강신구 안과 기구용 조명장치, 안과 기구 및 그 조명 방법
CN113925453A (zh) * 2021-11-11 2022-01-14 重庆康华瑞明科技股份有限公司 一种附加在眼科裂隙灯显微镜上的眼表泪膜脂质层照明装置
CN114098628A (zh) * 2021-11-11 2022-03-01 重庆康华瑞明科技股份有限公司 一种附加在角膜地形图上的眼表泪膜脂质层照明装置
US11471475B1 (en) 2022-03-08 2022-10-18 Ralph P. Stone Ophthalmic suspension vehicles and related methods for pharmaceutical ingredient delivery
US11679078B1 (en) 2022-03-08 2023-06-20 EternaTear, Inc. Ophthalmic formulations and related methods
US20230371807A1 (en) * 2022-05-19 2023-11-23 Yi Wang Illumination device for tear film lipid layer on ocular surface attached to corneal topography

Family Cites Families (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL43224A (en) 1973-09-14 1979-07-25 Yeda Res & Dev Fluorescence polarization measurements
US3941901A (en) 1974-02-15 1976-03-02 Hoffmann-La Roche Inc. Surface alignment method for liquid crystal cells and production of polarizers therefor
IL49622A0 (en) 1976-05-21 1976-07-30 Elscint Ltd A method and apparatus for classifying biological cells
DE3108878C2 (de) * 1981-03-09 1983-08-18 Franz-Josef Prof. Dr. Haberich Verfahren zur Untersuchung des Benetzungszustands und/oder des Benetzungsverlaufs einer konvexen Oberfläche und Vorrichtung zur Durchführung des Verfahrens
EP0064111B1 (fr) 1981-05-05 1986-02-05 Jacques Duparchy Dispositif pour observer et/ou photographier l'oeil d'un patient en vue de l'adaption d'une lentille de contact
US4705037A (en) 1985-02-08 1987-11-10 Peyman Gholam A Topographical mapping, depth measurement, and cutting systems for performing radial keratotomy and the like
US4747683A (en) * 1986-01-17 1988-05-31 Eye Research Institute Of Retina Foundation Method and device for in vivo wetting determinations
US4885352A (en) 1987-03-11 1989-12-05 Dowbrands Inc. Transparent plastic film comprising low density polyethylene
US4842401A (en) * 1987-06-15 1989-06-27 The Board Of Trustees Of The Leland Stanford Jr. University Eye diagnosis process
JPH024310A (ja) * 1988-06-16 1990-01-09 Kowa Co 眼科診断方法および装置
US5491097A (en) 1989-06-15 1996-02-13 Biocircuits Corporation Analyte detection with multilayered bioelectronic conductivity sensors
US5268305A (en) 1989-06-15 1993-12-07 Biocircuits Corporation Multi-optical detection system
US5110200A (en) 1989-06-30 1992-05-05 Technitex, Inc. Video keratometer
USD330769S (en) * 1989-10-25 1992-11-03 Carl-Zeiss-Stiftung, Heidenheim-Brenz Confocal laser-scanning ophthalmoscope
US5258791A (en) 1990-07-24 1993-11-02 General Electric Company Spatially resolved objective autorefractometer
JP3223512B2 (ja) 1990-12-19 2001-10-29 ソニー株式会社 画像表示方法及び装置
ZA927277B (en) * 1991-10-02 1993-05-19 Boston Ocular Res Dry eye treatment process and solution.
US5841511A (en) 1992-06-02 1998-11-24 Eyesys Technologies, Inc. Method of corneal analysis using a checkered placido apparatus
JP3318397B2 (ja) * 1992-08-27 2002-08-26 興和株式会社 微粒子計測装置
US5342137A (en) * 1993-01-11 1994-08-30 Peng Chih Wen Swing arm
JPH06269412A (ja) * 1993-03-19 1994-09-27 Canon Inc 視線検出装置及びそれを有した光学装置
JP3445635B2 (ja) 1993-03-31 2003-09-08 株式会社ニデック 眼科装置
US5712721A (en) 1993-04-07 1998-01-27 Technology Partnership, Plc Switchable lens
JPH07136120A (ja) * 1993-11-11 1995-05-30 Kowa Co 眼科装置
US5475452A (en) 1994-02-24 1995-12-12 Keravision, Inc. Device and method for mapping objects
US5515864A (en) 1994-04-21 1996-05-14 Zuckerman; Ralph Method and apparatus for the in vivo measurement of oxygen concentration levels by the indirect determination of fluoescence lifetime
JPH0852112A (ja) 1994-08-12 1996-02-27 Kowa Co 眼科涙液観察装置
JPH0898811A (ja) * 1994-09-30 1996-04-16 Nippon Contact Lens Kk 涙液膜観察補助装置
US5647032A (en) * 1995-08-24 1997-07-08 Kowa Company, Ltd. Interferometers for measuring coherence length and high-speed switching of laser light
SE9503028D0 (sv) 1995-09-01 1995-09-01 Pharmacia Biosensor Ab Method of analysing chemical and physical interactions at a sensor surface
USD394505S (en) * 1996-07-09 1998-05-19 Canon Kabushiki Kaisha Non-contact eye-pressure measuring apparatus
US5760950A (en) 1996-07-25 1998-06-02 Advanced Scanning, Ltd. Scanning confocal microscope
JP3600377B2 (ja) * 1996-07-30 2004-12-15 興和株式会社 眼科装置
US6447119B1 (en) * 1996-08-12 2002-09-10 Visionrx, Inc. Apparatus for visualizing the eye's tear film
US5873832A (en) 1996-08-12 1999-02-23 Xeyex Corporation Method and apparatus for measuring properties of the eye using a virtual image
US5886767A (en) * 1996-10-09 1999-03-23 Snook; Richard K. Keratometry system and method for measuring physical parameters of the cornea
US6198540B1 (en) * 1997-03-26 2001-03-06 Kowa Company, Ltd. Optical coherence tomography have plural reference beams of differing modulations
US5988815A (en) * 1997-10-24 1999-11-23 Tomey Co., Ltd. Pattern illumination device
JP3896211B2 (ja) 1998-03-20 2007-03-22 興和株式会社 眼科測定装置
US6236459B1 (en) * 1998-11-05 2001-05-22 University Of Miami Thin film measuring device and method
JP3699853B2 (ja) * 1999-02-18 2005-09-28 株式会社ニデック 眼科装置
KR100420201B1 (ko) 1999-11-12 2004-02-26 가네가후치 가가쿠 고교 가부시키가이샤 투명필름
US20050119737A1 (en) 2000-01-12 2005-06-02 Bene Eric A. Ocular implant and methods for making and using same
JP3647351B2 (ja) * 2000-03-22 2005-05-11 株式会社ニデック 眼科装置
US6659613B2 (en) * 2000-03-27 2003-12-09 Board Of Regents, The University Of Texas System Methods and systems for measuring local scattering and aberration properties of optical media
JP3718104B2 (ja) * 2000-05-01 2005-11-16 株式会社ニデック 眼科装置
AU2001281632A1 (en) 2000-08-09 2002-02-18 Artificial Sensing Instruments Asi Ag Waveguide grid array and optical measurement arrangement
US6736507B2 (en) * 2001-01-22 2004-05-18 Alexis Kudryashov High resolution, multispectral, wide field of view retinal imager
JP4694025B2 (ja) * 2001-04-18 2011-06-01 株式会社トプコン 眼特性測定装置
US7121666B2 (en) * 2001-04-25 2006-10-17 Tseng Scheffer C G Apparatus and method for the kinetic analysis of tear stability
USD465850S1 (en) * 2001-05-08 2002-11-19 Canon Kabushiki Kaisha Refractometer
USD462637S1 (en) * 2001-07-09 2002-09-10 Sarl Carre D'art Vase
JP3667268B2 (ja) * 2001-09-26 2005-07-06 得一郎 長谷川 アイマスク
US20050019488A1 (en) 2001-11-30 2005-01-27 Cambridge Polymer Group, Inc., Boston, Ma Layered aligned polymer structures and methods of making same
USD472637S1 (en) 2002-03-28 2003-04-01 Welch Allyn, Inc. Eye disease screening instrument
EP1391176A1 (en) 2002-08-16 2004-02-25 Universiteit Maastricht Method and arrangement for performing measurements of the topography of a corneal surface
US7241012B2 (en) * 2003-01-21 2007-07-10 Kabushiki Kaisha Topcon Ophthalmologic apparatus
GB2407378B (en) 2003-10-24 2006-09-06 Lein Applied Diagnostics Ltd Ocular property measuring apparatus and method therefor
WO2005067651A2 (en) 2004-01-08 2005-07-28 Cappo Anthony P Surface plasmon resonance based nanoliter tear osmometer
JP4471680B2 (ja) * 2004-02-20 2010-06-02 株式会社トプコン 眼科装置
US7310182B2 (en) 2004-02-20 2007-12-18 Intel Corporation Method and apparatus for modulating an optical beam in an optical device with a photonic crystal lattice
JP2006082262A (ja) * 2004-09-14 2006-03-30 Canon Inc 画像処理装置およびジョブ処理方法およびコンピュータが読み取り可能なプログラムを格納した記憶媒体およびプログラム
US7281801B2 (en) * 2004-09-15 2007-10-16 University Of Rochester Tear dynamics measured with optical coherence tomography
EP1820142A4 (en) * 2004-12-07 2010-03-10 Aoptix Technologies IRISIZATION WITH THE HELP OF THE EYE REFLECTION
US7073906B1 (en) * 2005-05-12 2006-07-11 Valdemar Portney Aspherical diffractive ophthalmic lens
US20060270802A1 (en) 2005-05-27 2006-11-30 Fuji Photo Film Co., Ltd. Optical functional film, composite film, and method for producing the same
EP1900320B1 (en) 2005-07-01 2014-04-30 Kowa Kabushiki Kaisha Ophthalmologic photographing device
USD607562S1 (en) * 2005-11-11 2010-01-05 Heine Optotechnik Gmbh & Co., Kg Ophthalmoscope
ATE516739T1 (de) 2005-12-06 2011-08-15 Zeiss Carl Meditec Ag Interferometrische probenmessung
JP4852316B2 (ja) * 2006-02-07 2012-01-11 則彦 横井 眼科装置
US7771353B2 (en) * 2006-04-11 2010-08-10 Reichert, Inc. Method and apparatus for tear film measurement
US7233396B1 (en) 2006-04-17 2007-06-19 Alphasniffer Llc Polarization based interferometric detector
USD582556S1 (en) * 2006-05-02 2008-12-09 Kabushiki Kaisha Topcon Fundus camera
USD552736S1 (en) * 2006-05-02 2007-10-09 Kabushiki Kaisha Topcon Ophthalmic instrument
US20070291277A1 (en) 2006-06-20 2007-12-20 Everett Matthew J Spectral domain optical coherence tomography system
EP2077753B1 (en) 2006-09-12 2012-12-19 The General Hospital Corporation Apparatus, probe and method for providing depth assessment in an anatomical structure
SG177910A1 (en) * 2006-12-21 2012-02-28 Johnson & Johnson Vision Care Cuvette for ophthalmic lens
US8345191B2 (en) 2007-02-06 2013-01-01 Tcl Corporation Liquid crystal display device having optical component for changing state of polarized light
AU2008247423B2 (en) * 2007-05-04 2013-10-31 Abbott Medical Optics Inc. Methods and devices for measuring tear film and diagnosing tear disorders
US7959293B2 (en) * 2007-05-04 2011-06-14 Abbott Medical Optics Inc. Methods and devices for measuring tear film and diagnosing tear disorders
US7758190B2 (en) * 2007-06-20 2010-07-20 Tearscience, Inc. Tear film measurement
US8192026B2 (en) * 2007-06-20 2012-06-05 Tearscience, Inc. Tear film measurement
EP2189108A4 (en) 2007-08-16 2013-10-09 Shiro Amano DEVICE FOR MONITORING MOMENTARY DRUGS
JP2009134276A (ja) 2007-11-05 2009-06-18 Panasonic Corp 表示装置、表示方法、表示プログラム、集積回路、眼鏡型ヘッドマウントディスプレイ、自動車、単眼鏡、及び据置型ディスプレイ
GB0802290D0 (en) 2008-02-08 2008-03-12 Univ Kent Canterbury Camera adapter based optical imaging apparatus
WO2009135084A1 (en) 2008-04-30 2009-11-05 Amo Development, Llc System and method for controlling measurement in an eye during ophthalmic procedure
JP2010104422A (ja) 2008-10-28 2010-05-13 Fujifilm Corp 撮像システムおよび撮像方法
EP2420180B1 (en) * 2009-04-01 2019-05-22 Tearscience, Inc. Apparatus for measuring ocular tear film layer thickness(es)
US8256898B2 (en) 2009-06-12 2012-09-04 The Regents Of The University Of California Method and device for tear film analysis
US8810417B2 (en) 2009-08-28 2014-08-19 The Invention Science Fund I, Llc Beverage immersate with detection capability
JP5350178B2 (ja) 2009-10-23 2013-11-27 キヤノン株式会社 補償光学装置、補償光学装置を備える撮像装置、補償光学方法
WO2011097508A2 (en) 2010-02-04 2011-08-11 University Of Southern California Combined spectral and polarimetry imaging and diagnostics
US20110237999A1 (en) 2010-03-19 2011-09-29 Avedro Inc. Systems and methods for applying and monitoring eye therapy
JP5856385B2 (ja) 2011-04-08 2016-02-09 株式会社トプコン 眼科画像解析装置、及び眼科画像解析プログラム
US8641194B2 (en) 2011-07-08 2014-02-04 Johnson & Johnson Vision Care, Inc. System for in vivo analysis of tear film in the human eye via phase shifting interferometry
US8602557B2 (en) 2011-12-02 2013-12-10 Abbott Medical Optics Inc. Method for calculating tear film lipid and aqueous layer thickness and corneal surface refractive index from interferometry data
KR101259056B1 (ko) 2012-01-06 2013-04-29 가톨릭대학교 산학협력단 광간섭성 단층촬영을 이용한 3차원 마이봄샘 촬영방법

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of EP2166922A4 *

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10004396B2 (en) 2009-04-01 2018-06-26 Tearscience, Inc. Ocular surface interferometry (OSI) devices and systems for imaging, processing, and/or displaying an ocular tear film
US8915592B2 (en) 2009-04-01 2014-12-23 Tearscience, Inc. Apparatuses and methods of ocular surface interferometry (OSI) employing polarization and subtraction for imaging, processing, and/or displaying an ocular tear film
US9642520B2 (en) 2009-04-01 2017-05-09 Tearscience, Inc. Background reduction apparatuses and methods of ocular surface interferometry (OSI) employing polarization for imaging, processing, and/or displaying an ocular tear film
US9662008B2 (en) 2009-04-01 2017-05-30 Tearscience, Inc. Ocular surface interferometry (OSI) devices and systems for imaging, processing, and/or displaying an ocular tear film
US11771317B2 (en) 2009-04-01 2023-10-03 Tearscience, Inc. Ocular surface interferometry (OSI) for imaging, processing, and/or displaying an ocular tear film
US9693682B2 (en) 2009-04-01 2017-07-04 Tearscience, Inc. Ocular surface interferometry (OSI) devices and systems for imaging, processing, and/or displaying an ocular tear film
US11259700B2 (en) 2009-04-01 2022-03-01 Tearscience Inc Ocular surface interferometry (OSI) for imaging, processing, and/or displaying an ocular tear film
US9888839B2 (en) 2009-04-01 2018-02-13 Tearscience, Inc. Methods and apparatuses for determining contact lens intolerance in contact lens wearer patients based on dry eye tear film characteristic analysis and dry eye symptoms
US9999346B2 (en) 2009-04-01 2018-06-19 Tearscience, Inc. Background reduction apparatuses and methods of ocular surface interferometry (OSI) employing polarization for imaging, processing, and/or displaying an ocular tear film
US10716465B2 (en) 2009-04-01 2020-07-21 Johnson & Johnson Vision Care, Inc. Methods and apparatuses for determining contact lens intolerance in contact lens wearer patients based on dry eye tear film characteristic analysis and dry eye symptoms
US10582848B2 (en) 2009-04-01 2020-03-10 Tearscience, Inc. Ocular surface interferometry (OSI) devices and systems for imaging, processing, and/or displaying an ocular tear film
JP2012522594A (ja) * 2009-04-01 2012-09-27 テイアサイエンス・インコーポレーテツド 眼球涙液膜の画像形成、処理および/または表示を行いおよび/または眼球涙液膜層の厚さを測定する、眼球表面の干渉分光(osi)装置、システムおよび方法
US10244939B2 (en) 2012-12-21 2019-04-02 Tearscience, Inc. Full-eye illumination ocular surface imaging of an ocular tear film for determining tear film thickness and/or providing ocular topography
US10582849B2 (en) 2012-12-21 2020-03-10 Tearscience, Inc. Full-eye illumination ocular surface imaging of an ocular tear film for determining tear film thickness and/or providing ocular topography
US9993151B2 (en) 2012-12-21 2018-06-12 Tearscience, Inc. Full-eye illumination ocular surface imaging of an ocular tear film for determining tear film thickness and/or providing ocular topography
US9668647B2 (en) 2012-12-21 2017-06-06 Tearscience Inc. Full-eye illumination ocular surface imaging of an ocular tear film for determining tear film thickness and/or providing ocular topography
US10278587B2 (en) 2013-05-03 2019-05-07 Tearscience, Inc. Eyelid illumination systems and method for imaging meibomian glands for meibomian gland analysis
US11141065B2 (en) 2013-05-03 2021-10-12 Tearscience, Inc Eyelid illumination systems and methods for imaging meibomian glands for meibomian gland analysis
US10512396B2 (en) 2013-11-15 2019-12-24 Tearscience, Inc. Ocular tear film peak detection and stabilization detection systems and methods for determining tear film layer characteristics
US9795290B2 (en) 2013-11-15 2017-10-24 Tearscience, Inc. Ocular tear film peak detection and stabilization detection systems and methods for determining tear film layer characteristics

Also Published As

Publication number Publication date
US20080316499A1 (en) 2008-12-25
EP2166922A2 (en) 2010-03-31
JP5665181B2 (ja) 2015-02-04
JP2010530282A (ja) 2010-09-09
WO2008156883A3 (en) 2009-12-30
US7988294B2 (en) 2011-08-02
EP2166922A4 (en) 2012-03-28
US7758190B2 (en) 2010-07-20
US20100085540A1 (en) 2010-04-08
US8591033B2 (en) 2013-11-26
US20110285961A1 (en) 2011-11-24

Similar Documents

Publication Publication Date Title
US8591033B2 (en) Tear film measurement
US8192026B2 (en) Tear film measurement
Guillon Use of the Tearscope Plus and attachments in the routine examination of the marginal dry eye contact lens patient
US5512965A (en) Ophthalmic instrument and method of making ophthalmic determinations using Scheimpflug corrections
Wang et al. Relationships between central tear film thickness and tear menisci of the upper and lower eyelids
US6447119B1 (en) Apparatus for visualizing the eye's tear film
CA2911294C (en) Eyelid illumination systems and methods for imaging meibomian glands for meibomian gland analysis
US11564563B2 (en) Apparatus and method of a multifunctional ophthalmic instrument
US9888839B2 (en) Methods and apparatuses for determining contact lens intolerance in contact lens wearer patients based on dry eye tear film characteristic analysis and dry eye symptoms
CN106510615B (zh) 干眼症综合分析系统
US4423931A (en) Fundus camera accessory for analysis of the ocular fundus contour
JP2004535880A (ja) 白内障を検査し定量化するための機器及び方法
JP2017526507A (ja) 目を解析するためのシステム及び方法
CN207055477U (zh) 干眼症综合分析系统
Himebaugh et al. Use of retroillumination to visualize optical aberrations caused by tear film break-up
CN110367926A (zh) 一种应用于自助医疗的干眼症检查装置及方法
US20220313086A1 (en) Ophthalmoscope for examining eyes
Kunumpol et al. GlauCUTU: virtual reality visual field test
CN106725283A (zh) 便携式干眼症检测仪
EP0663179A1 (en) Spatial refractometer
JP3387500B2 (ja) 市松模様のプラシード装置
KR101542938B1 (ko) 눈물막 기름층 관찰 장치
WO2015073664A2 (en) Apparatuses and methods for detecting lid margin contact and blink rates, particularly for diagnosing, measuring, and/or analyzing dry eye conditions and symptoms
Yao et al. Measurement of the lower lid margin thickness by oculus keratograph
Baumbach et al. Absolute ocular fundus dimensions measured by multiple-beam interference fringes.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08732520

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2010513285

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2008732520

Country of ref document: EP